In vivo lentivirus-based macrophage reprogramming typically involves genetic modification of macrophages using lentiviral vectors. This approach provides a powerful tool to explore and utilize the potential of macrophages in various biological and medical applications. As a pioneer in the tumor-immunity field, Creative Biolabs integrates lentivirus-based cell modification with macrophage reprogramming and successfully developed a series of in vivo lentivirus-based macrophage reprogramming services to assist the application of macrophage for disease treatment.
Lentiviral vectors are the preferred choice for in vivo reprogramming techniques because they offer the following advantages.
Macrophage reprogramming utilizes lentiviral vectors that can efficiently introduce specific genes or regulatory molecules to reprogram macrophages. This process can be carried out in an in vivo environment, ensuring that the experimental results are closer to the physiological state and greatly enhancing the relevance and validity of the research.
In vivo lentivirus-based macrophage reprogramming services are widely used in the following areas:
We utilize the lentivirus vectors to deliver the desired gene into the macrophage for in vivo engineering purposes. Throughout the process, we provide comprehensive customized services from lentivirus production to results visualization to meet global customers' diverse needs.
In term of different diseases and targets, we provide several related services and diverse target genes that can be chosen from for your projects:
Service | Targets |
---|---|
In Vivo Lentivirus-based Macrophage Reprogramming Service for Cancer | IFN-α; CSF1; PTX3; IL-1; LILRB1; MRC1; PD-1 TREM2; PSGL1 |
In Vivo Lentivirus-based Macrophage Reprogramming Service for Neurol-disease | BDNF; ApoAI; STAT1; STAT6; VEGF; NF-κB; M-CSFR; ADAM8 |
In Vivo Lentivirus-based Macrophage Reprogramming Service for Inflammation | IL-12; IL-6; MCP-1; TNF-α; IL-10; TGF-β; IL-1β |
Importantly, we also provide a lentivirus production service featuring strict quality control to deliver high-quality lentivirus productions for global customers.
Key features of this service:
As a pioneer in the field, Creative Biolabs is committed to innovating technologies to aid in the development of disease treatment and improve human life quality. Here we provide an inquiry mode for your convenience to contact us. We are glad to receive your inquiry to know more about in vivo lentivirus-based macrophage reprogramming services.
High-quality lentiviral vectors are required for efficient reprogramming of macrophages in vivo. Our products provide a solution to this need. By combining advanced macrophage reprogramming techniques with efficient tools, researchers can explore the role of macrophages in disease more comprehensively, laying the foundation for the development of new immunotherapeutic strategies.
Cat.No | Product Name | Product Type |
---|---|---|
MTS-0922-JF10 | Human Macrophages, Alveolar | Human Macrophages |
MTS-0922-JF99 | Human M0 Macrophages, 1.5 x 10^6 | Human M0 Macrophages |
MTS-0922-JF52 | C57/129 Mouse Macrophages, Bone Marrow | C57/129 Mouse Macrophages |
MTS-0922-JF7 | Human M2 Macrophages, Peripheral Blood, 10 x 10^6 | Human M2 Macrophages |
MTS-0922-JF34 | CD1 Mouse Macrophages | CD1 Mouse Macrophages |
MTS-1223-LX1 | IL-12 Lentiviral Particle for Macrophage Engineering | Virus Particles |
MTS-0124-LX2 | IFN-α Lentiviral Particle for Macrophage Engineering | Virus Particles |
MTS-0124-LX7 | TNF-α Lentiviral Particle for Macrophage Engineering | Virus Particles |
MTS-0124-LX11 | GM-CSF Lentiviral Particle for Macrophage Engineering | Virus Particles |
MTS-0124-LX17 | Anti-CTLA4 antibody Lentiviral Particle for Macrophage Engineering | Virus Particles |
Chimeric antigen receptor macrophage (CAR-M) therapy is a novel cancer immunotherapy that integrates CAR structure and macrophage function. Yi Huo et al. constructed a novel HER2-targeted CAR-M that was able to efficiently eliminate HER2-positive tumor cells both in vivo and in vitro, and M1 polarization significantly enhanced the anti-tumor ability of CAR-M.
In their experiments, they synthesized anti-HER2 CAR sequences and cloned them into lentiviral vector backbones, followed by virus production in cells using a third-generation lentiviral packaging system. The lentiviral supernatant was concentrated and added to mouse BMDM for transduction.
Fig. 1 Overview of primary macrophage differentiation from bone marrow and the lentivirus transduction protocol.1,2
Q: What research areas are your services applicable to?
A: Our macrophage reprogramming service is applicable to a number of research areas, including basic immunology, cancer research, inflammatory diseases, infection modeling, and regenerative medicine. Whether you wish to explore the role of macrophages in a specific disease or develop new therapeutic strategies, all are scenarios where our service is applicable.
Q: How long do reprogrammed macrophages last?
A: The survival time of reprogrammed macrophages varies depending on the experimental conditions, and typically these cells can continue to proliferate and function for weeks to months under appropriate culture conditions. We recommend assessing the cell status periodically to ensure that the experiment runs smoothly.
Q: What support can you provide to assist customers in designing experiments?
A: We provide comprehensive experimental design support, including consulting services to identify optimal reprogramming genes, select appropriate cell types, optimize infection conditions, and develop subsequent experimental procedures. Our scientific team will provide personalized advice and guidance based on the client's research objectives to ensure that the experimental design is sound and can achieve the desired results.
Q: Can customers select specific genes for reprogramming?
A: Yes, customers can customize the genes they want to reprogram according to their research needs. We will assist customers in evaluating the suitability of the selected genes and provide relevant technical advice to ensure that the selected genes can effectively achieve the desired reprogramming effect.
References
Copyright © 2025 Creative Biolabs. All Rights Reserved.